Elevance Health Current Ratio 2010-2024 | ELV
Current and historical current ratio for Elevance Health (ELV) from 2010 to 2024. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations. Elevance Health current ratio for the three months ending March 31, 2024 was 1.38.
| Elevance Health Current Ratio Historical Data | |||
|---|---|---|---|
| Date | Current Assets | Current Liabilities | Current Ratio |
| 2024-03-31 | $60.95B | $44.33B | 1.38 |
| 2023-12-31 | $60.03B | $41.79B | 1.44 |
| 2023-09-30 | $61.19B | $43.34B | 1.41 |
| 2023-06-30 | $59.74B | $41.57B | 1.44 |
| 2023-03-31 | $59.82B | $41.89B | 1.43 |
| 2022-12-31 | $55.62B | $39.70B | 1.40 |
| 2022-09-30 | $55.60B | $41.29B | 1.35 |
| 2022-06-30 | $53.66B | $39.31B | 1.37 |
| 2022-03-31 | $53.90B | $39.73B | 1.36 |
| 2021-12-31 | $51.12B | $34.89B | 1.47 |
| 2021-09-30 | $51.90B | $35.16B | 1.48 |
| 2021-06-30 | $50.24B | $33.79B | 1.49 |
| 2021-03-31 | $54.50B | $34.75B | 1.57 |
| 2020-12-31 | $45.75B | $29.45B | 1.55 |
| 2020-09-30 | $45.45B | $28.56B | 1.59 |
| 2020-06-30 | $46.76B | $28.52B | 1.64 |
| 2020-03-31 | $41.26B | $27.04B | 1.53 |
| 2019-12-31 | $39.03B | $23.53B | 1.66 |
| 2019-09-30 | $39.50B | $23.23B | 1.70 |
| 2019-06-30 | $37.81B | $23.09B | 1.64 |
| 2019-03-31 | $36.61B | $22.68B | 1.61 |
| 2018-12-31 | $34.32B | $21.97B | 1.56 |
| 2018-09-30 | $37.11B | $24.17B | 1.54 |
| 2018-06-30 | $37.37B | $24.51B | 1.53 |
| 2018-03-31 | $36.97B | $24.76B | 1.49 |
| 2017-12-31 | $36.26B | $23.36B | 1.55 |
| 2017-09-30 | $36.97B | $24.41B | 1.52 |
| 2017-06-30 | $37.13B | $22.57B | 1.65 |
| 2017-03-31 | $37.98B | $23.17B | 1.64 |
| 2016-12-31 | $34.32B | $21.29B | 1.61 |
| 2016-09-30 | $32.92B | $21.04B | 1.57 |
| 2016-06-30 | $32.96B | $20.82B | 1.58 |
| 2016-03-31 | $32.97B | $20.81B | 1.58 |
| 2015-12-31 | $30.86B | $19.09B | 1.62 |
| 2015-09-30 | $31.54B | $18.37B | 1.72 |
| 2015-06-30 | $33.20B | $20.67B | 1.61 |
| 2015-03-31 | $34.74B | $21.31B | 1.63 |
| 2014-12-31 | $31.95B | $18.75B | 1.70 |
| 2014-09-30 | $32.23B | $18.40B | 1.75 |
| 2014-06-30 | $32.43B | $19.18B | 1.69 |
| 2014-03-31 | $31.81B | $18.49B | 1.72 |
| 2013-12-31 | $29.75B | $16.35B | 1.82 |
| 2013-09-30 | $29.60B | $16.04B | 1.85 |
| 2013-06-30 | $28.90B | $16.03B | 1.80 |
| 2013-03-31 | $28.66B | $16.03B | 1.79 |
| 2012-12-31 | $29.35B | $16.00B | 1.84 |
| 2012-09-30 | $29.64B | $14.08B | 2.11 |
| 2012-06-30 | $28.47B | $16.18B | 1.76 |
| 2012-03-31 | $27.54B | $15.96B | 1.73 |
| 2011-12-31 | $27.10B | $15.90B | 1.70 |
| 2011-09-30 | $27.55B | $15.79B | 1.75 |
| 2011-06-30 | $26.76B | $14.11B | 1.90 |
| 2011-03-31 | $26.82B | $14.16B | 1.89 |
| 2010-12-31 | $26.14B | $14.01B | 1.87 |
| 2010-09-30 | $26.94B | $14.14B | 1.91 |
| 2010-06-30 | $26.08B | $14.84B | 1.76 |
| 2010-03-31 | $27.12B | $14.81B | 1.83 |
| 2009-12-31 | $28.07B | $14.67B | 1.91 |
| 2009-09-30 | $25.36B | $14.13B | 1.80 |
| 2009-06-30 | $25.00B | $14.34B | 1.74 |
| 2009-03-31 | $12.48B | $15.34B | 0.81 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $124.299B | $171.340B |
| Elevance Health Inc. operates as a health benefits company. It supports consumers, families and communities across the entire care journey connecting to the care, support and resources to lead healthier lives. Elevance Health Inc., formerly known as Anthem Inc., is based in Indianapolis, Indiana. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cencora (COR) | United States | $46.379B | 18.08 |
| ICON (ICLR) | Ireland | $25.848B | 24.40 |
| DiDi Global (DIDIY) | China | $20.706B | 0.00 |
| Avantor (AVTR) | United States | $14.726B | 21.68 |
| CochLear (CHEOY) | Australia | $13.973B | 0.00 |
| Natera (NTRA) | United States | $13.533B | 0.00 |
| Revvity (RVTY) | United States | $13.407B | 23.52 |
| Medpace Holdings (MEDP) | United States | $12.205B | 40.15 |
| Viatris (VTRS) | United States | $12.109B | 3.62 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $10.989B | 0.00 |
| Charles River Laboratories (CRL) | United States | $10.790B | 20.66 |
| Solventum (SOLV) | United States | $9.423B | 0.00 |
| Sonic Healthcare (SKHHY) | Australia | $7.951B | 0.00 |
| HealthEquity (HQY) | United States | $7.177B | 46.08 |
| Doximity (DOCS) | United States | $5.537B | 38.78 |
| Bausch + Lomb (BLCO) | Canada | $5.309B | 21.25 |
| Organon (OGN) | United States | $5.246B | 4.98 |
| PACS (PACS) | United States | $4.392B | 0.00 |
| Life Times (LTH) | United States | $3.563B | 37.33 |
| Sotera Health (SHC) | United States | $3.281B | 16.10 |
| GoodRx Holdings (GDRX) | United States | $3.193B | 121.57 |
| Surgery Partners (SGRY) | United States | $3.177B | 29.07 |
| Agilon Health (AGL) | United States | $2.838B | 0.00 |
| Progyny (PGNY) | United States | $2.569B | 44.23 |
| NovoCure (NVCR) | Jersey | $2.296B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $2.102B | 8.33 |
| Premier (PINC) | United States | $1.927B | 8.24 |
| BrightSpring Health Services (BTSG) | United States | $1.794B | 0.00 |
| Teladoc Health (TDOC) | United States | $1.696B | 0.00 |
| Alignment Healthcare (ALHC) | United States | $1.591B | 0.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.566B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.224B | 0.00 | |
| GeneDx Holdings (WGS) | United States | $0.752B | 0.00 |
| CareDx (CDNA) | United States | $0.739B | 0.00 |
| Embecta (EMBC) | United States | $0.738B | 5.02 |
| InnovAge Holding (INNV) | United States | $0.691B | 0.00 |
| Pediatrix Medical (MD) | United States | $0.609B | 6.46 |
| Auna S.A (AUNA) | Luxembourg | $0.600B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.583B | 15.27 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.455B | 0.00 |
| Enhabit (EHAB) | United States | $0.441B | 44.00 |
| ModivCare (MODV) | United States | $0.375B | 7.02 |
| Sonida Senior Living (SNDA) | United States | $0.369B | 0.00 |
| LifeMD (LFMD) | United States | $0.329B | 0.00 |
| DocGo (DCGO) | United States | $0.294B | 16.06 |
| Sharecare (SHCR) | United States | $0.292B | 0.00 |
| MultiPlan (MPLN) | United States | $0.281B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.261B | 0.00 |
| Beauty Health (SKIN) | United States | $0.244B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.196B | 0.00 |
| Biodesix (BDSX) | United States | $0.184B | 0.00 |
| So-Young (SY) | China | $0.114B | 55.25 |
| Pono Capital Two (PTWO) | United States | $0.072B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.050B | 0.00 |
| NeueHealth (NEUE) | United States | $0.044B | 5.99 |
| IceCure Medical (ICCM) | Israel | $0.037B | 0.00 |
| Oncology Institute (TOI) | United States | $0.034B | 0.00 |
| Nutex Health (NUTX) | United States | $0.027B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.027B | 0.00 |
| BIMI Holdings (BIMI) | United States | $0.024B | 0.00 |
| Singular Genomics Systems (OMIC) | United States | $0.024B | 0.00 |
| OncoCyte (OCX) | United States | $0.023B | 0.00 |
| KindlyMD (KDLY) | $0.016B | 0.00 | |
| SeaStar Medical Holding (ICU) | United States | $0.012B | 0.00 |
| DermTech (DMTK) | United States | $0.011B | 0.00 |
| XWELL (XWEL) | United States | $0.011B | 0.00 |
| TRxADE HEALTH (MEDS) | United States | $0.009B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.008B | 0.00 | |
| ISpecimen (ISPC) | United States | $0.007B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.006B | 0.00 |
| NewGenIvf Group (NIVF) | Singapore | $0.004B | 0.00 |
| OpGen (OPGN) | United States | $0.003B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |
| Assure Holdings (IONM) | United States | $0.002B | 0.00 |